Literature DB >> 16563877

Role of HLA-B51 and HLA-B52 in susceptibility to pulmonary tuberculosis.

V Vijaya Lakshmi1, Shilpa S Rakh, B Anu Radha, V Hari Sai Priya, Vinod Pantula, Susmita Jasti, G Suman Latha, K J R Murthy.   

Abstract

MHC class I-restricted CD8+ T cells are important for the generation of protective immune responses in MTB infection. CD8+ CTL (cytotoxic T-lymphocyte)-derived IFN-g may be especially important both for cells lacking MHC class II molecules, e.g. in the lung and for macrophages where mycobacteria can evade recognition during chronic infection by sequestering their antigens away from sensitized CD4+ T cells. This study was designed to detect any association of MHC class I (HLA-B) molecules with pulmonary tuberculosis. A total of 75 individuals, comprising of 33 patients with pulmonary tuberculosis; 12 HIV patients who developed tuberculosis and 30 healthy controls, were included in the study. They were typed for HLA-B by the PCR-SSP method. The results of only HLA-B alleles, which are highly significant, are presented here. The number of healthy individuals with HLA-B52 was significantly high when compared to the patient groups (healthy versus TB: 21.2% versus 0.0%, OR=0.0, P<0.0001, P(c)=0.003; healthy versus HIV-TB: 21.2% versus 16.7%; OR=0.74; P<0.001; P(c)=0.003). In contrast, the number of patients, both TB- and HIV-TB-positive, with HLA-B51 was significantly high when compared to the healthy group of individuals (TB versus healthy: 36.7% versus 3%; OR=18.53; P<0.0001; P(c)=0.001; HIV-TB versus healthy: 41.7% versus 3%; OR=22.86; P<0.0001; P(c)=0.001). Only one healthy control was positive to HLA-B51; however this individual also had HLA-B52. The results of this study suggest that HLA-B52(5) has a negative, i.e. a protective association and HLA-B51(5) has a positive (susceptible) association, for pulmonary tuberculosis. Studies on HLA-B51 and HLA-B52 in a larger population to assess their role in tuberculosis may be useful for TB-vaccination strategies, since HLA profiles are likely to be related to vaccine efficacy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563877     DOI: 10.1016/j.meegid.2006.02.002

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  7 in total

1.  Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.

Authors:  Ming-Han Chloe Tsai; Supriya Singh; Emily Adland; Philip Goulder
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Association of the HLA-B*52 allele with non-progression to AIDS in Brazilian HIV-1-infected individuals.

Authors:  S L M Teixeira; N B R de Sá; D P Campos; A B Coelho; M L Guimarães; T C N F Leite; V G Veloso; M G Morgado
Journal:  Genes Immun       Date:  2014-04-10       Impact factor: 2.676

3.  The association of the PTPN22 620W polymorphism with Behcet's disease.

Authors:  Vijay Baranathan; Miles R Stanford; Robert W Vaughan; Elli Kondeatis; Elizabeth Graham; Farida Fortune; Wafa Madanat; Charlie Kanawati; Marwen Ghabra; Philip I Murray; Graham R Wallace
Journal:  Ann Rheum Dis       Date:  2007-07-27       Impact factor: 19.103

4.  Association between HLA-Class I and HLA-Class II Alleles and Mycobacterium Tuberculosis Infection in Iraqi Patients from Baghdad City.

Authors:  Nidhal Abdulmohaimen Mohammed; Haitham Qassem; Farouk Hassen
Journal:  Iran J Med Sci       Date:  2014-03

5.  An analysis of the epitope knowledge related to Mycobacteria.

Authors:  Martin J Blythe; Qing Zhang; Kerrie Vaughan; Romulo de Castro; Nima Salimi; Huynh-Hoa Bui; David M Lewinsohn; Joel D Ernst; Bjoern Peters; Alessandro Sette
Journal:  Immunome Res       Date:  2007-12-14

6.  Human leukocyte antigen class 1 genotype distribution and analysis in persons with active tuberculosis and household contacts from Central Uganda.

Authors:  Helen K Buteme; Rebecca Axelsson-Robertson; Lina Benson; Moses L Joloba; W Henry Boom; Gunilla Kallenius; Markus Maeurer
Journal:  BMC Infect Dis       Date:  2016-09-23       Impact factor: 3.090

7.  Clinical and genetic markers associated with tuberculosis, HIV-1 infection, and TB/HIV-immune reconstitution inflammatory syndrome outcomes.

Authors:  Nathalia Beatriz Ramos de Sá; Marcelo Ribeiro-Alves; Tatiana Pereira da Silva; Jose Henrique Pilotto; Valeria Cavalcanti Rolla; Carmem B W Giacoia-Gripp; Daniel Scott-Algara; Mariza Gonçalves Morgado; Sylvia Lopes Maia Teixeira
Journal:  BMC Infect Dis       Date:  2020-01-20       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.